From: Proceedings of the 27th European Paediatric Rheumatology Congress (PReS 2021)
Parameter | Vaccination against MMR | р | Vaccination against Diphtheria | p | ||
---|---|---|---|---|---|---|
continued (n=19) | declined (n=39) | continued (n=25) | declined (n=51) | |||
Duration of the JIA, g. | 6.9 (6.3;11.6) | 5.5 (3.2; 8.8) | 0.031 | 6.5 (4.9; 8.2) | 6.2 (3.6; 9.5) | 0.699 |
Antibodies, IgG, IU/mL (*measles only) | 0.2* (0,01; 0.6) | 0,16* (0.0; 0,46) | 0.775 | 0.14 (0.1; 0.34) | 0.06 (0.02; 0.22) | 0.695 |
Patients with a protective titer, n (%) | 9 (47.4) | 19 (48.7) | 0.923 | 15 (60.0) | 18 (35.3) | 0.041 |
Time since the last vaccination, y. | 4.8 (4.3;6.8) | 5.3 (3.6; 7.3) | 0.772 | 5.6 (3.6; 10.3) | 6.7 (4.0; 10.7) | 0.025 |